Encapsulation of amphotericin B in poly(ethylene glycol)-block-poly(ɛ-caprolactone-co-trimethylenecarbonate) polymeric micelles-Reference-Cited by-同舟云学术

Encapsulation of amphotericin B in poly(ethylene glycol)-block-poly(ɛ-caprolactone-co-trimethylenecarbonate) polymeric micelles

Published:2006-02 Issue:1-2 Volume:309 Page:234-240
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Vandermeulen G.,Rouxhet L.,Arien A.,Brewster M.E.,Préat V.

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference26 articles.

1. Relative aggregation state and hemolytic activity of amphotericin B encapsulated by poly(ethylene oxide)-block-poly(N-hexyl-l-aspartamide)-acyl conjugate micelles: effects of acyl chain length;Adams;J. Contr. Release,2003

2. Nouvelles formes lipidiques de l’amphotéricine B. Revue de la littèrature;Andrès;Rev. Med. Int.,2001

3. The effect of serum albumin on the aggregation state and toxicity of amphotericin B;Aramwit;J. Pharm. Sci.,2000

4. One-sided action of amphotericin B on cholesterol-containing membranes is determined by its self-association in the medium;Bolard;Biochemistry,1991

5. Therapeutic and hemolytic evaluation of in-situ liposomal preparation containing amphotericin-B complexed with different chemically modified β-cyclodextrins;Chakraborty;J. Pharm. Pharm. Sci.,2003

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Amphotericin B-loaded natural latex dressing for treating Candida albicans wound infections using Galleria mellonella model;Journal of Controlled Release;2024-01

2. Solubility, aggregation and stability of Amphotericin B drug in pure organic solvents: Thermodynamic analysis and solid form characterization;Journal of Molecular Liquids;2022-11

3. Amphotericin B-Loaded Plant-Inspired Polyphenol Nanoparticles Enhance Its Antifungal Activity and Biocompatibility;ACS Applied Bio Materials;2022-10-14

4. In-silico approach as a tool for selection of excipients for safer amphotericin B nanoformulations;Journal of Controlled Release;2022-09

5. Orally Administered Amphotericin B Nanoformulations: Physical Properties of Nanoparticle Carriers on Bioavailability and Clinical Relevance;Pharmaceutics;2022-08-30